Education

Fellowship
Hematology/Oncology, UCLA School of Medicine, 2006
Residency
Internal Medicine, University of Chicago Hospitals, 2002
Internship
Internal Medicine, University of Chicago Hospitals, 2000
Degree
MD, Washington University School of Medicine, 1999

Medical Board Certifications

Hematology
American Board of Internal Medicine, 2006
Medical Oncology
American Board of Internal Medicine, 2006

Gender

Male

State License

A82474
  • About Me

    About Me

    Dr. Garon received his MD degree from the Washington University School of Medicine in 1999, and his internal medicine training at the University of Chicago. He trained in Medical Oncology at UCLA, and joined the UCLA faculty in 2006. In 2008 he was appointed as an Assistant Professor of Medicine at the Geffen School of Medicine at UCLA in the Department of Medicine, Division of Hematology/ Oncology. Dr. Garon has been awarded a UCLA Lung SPORE Career Development Award in 2007, the Tower Cancer Research Foundation Career Development Award in 2008, a Lincy Foundation Grant in 2008, a NIH/NCI K23 award in 2011, a JCCC Seed Grant in 2012, and a STOP CANCER Norman Gilfenbain Memorial Seed Grant in 2014.

  • Locations

    UCLA Hematology Oncology Santa Monica

    (primary location)
    Address
    2020 Santa Monica Blvd
    Suite 600
    Santa Monica, California 90404
    Phone
    310-829-5471
  • Education

    Medical Board Certifications

    Hematology
    American Board of Internal Medicine, 2006
    Medical Oncology
    American Board of Internal Medicine, 2006

    Education

    Fellowship
    Hematology/Oncology, UCLA School of Medicine, 2006
    Residency
    Internal Medicine, University of Chicago Hospitals, 2002
    Internship
    Internal Medicine, University of Chicago Hospitals, 2000
    Degree
    MD, Washington University School of Medicine, 1999
  • Clinical Interests
    • Lung Cancer & Chest Malignancies
  • Research

    Research Interest

    Dr. Edward Garon is interested in the testing and development of targeted therapies and immunotherapies in the treatment of non-small cell lung cancer.

    Publications